Yue-qiu Zhang, Shao-xia Xu, Sai-nan Bian, Li-fan Zhang, Yao Zhang, Wei-hong Zhang, Ying-chun Xu and Xiao-qing Liu
, CLINIVIR, and DOSVIRC groups. Lancet 1997; 349(9055): 825-832.
7 Robinson JL, Doucette K. The natural history of hepatitisCvirus infection acquired during childhood. Liver Int 2012; 32:258-270.
8 Massard J, Ratziu V, Thabut D, Moussalli J, Lebray P, Benhamou Y, et al. Natural history and predictors of disease severity in chronic hepatitis C. J Hepatol 2006;44:19-24.
9 EASL Clinical Practice Guidelines: Management of hepatitisCvirus infection. European Association for the Study of the Liver. J Hepatol 2011; 55(2): 245
viral countermeasures. Biochim Biophys 2009;1793:1478-1484.
6 Feldstein A, Kleiner D, Kravetz D, Buck M. Severe hepatocellular injury with apoptosis induced by a hepatitis C polymerase inhibitor. J Clin Gastroenterol 2009;43:374-381.
7 Dreux M, Chisari FV. Impact of the autophagy machinery on hepatitisCvirus infection. Viruses 2011;3:1342-1357.
8 Sir D, Ann DK, Ou JH. Autophagy by hepatitis B virus and for hepatitis B virus. Autophagy 2010;6:4383-4388.
9 Coller KE, Berger KL, Heaton NS, Cooper JD, Yoon
Radka T. Komitova, Maria V. Atanasova, Toska A. Pavlova, Monica Sh. Nyagolov and Aneta V. Ivanova
1. Izopet J, Sandres-Sauné K, Kamar N, et al. Incidence of HCV infection in French hemodialysis units: a prospective study. J Med Virol 2005;77(1):70-6.
2. Hinrichsen H, Leimenstoll G, Stegen G, et al. Prevalence and risk factors of hepatitisCvirus infection in haemodialysis patients: a multicentre study in 2796 patients. Gut 2002;51(3):429-33.
3. Jadoul M, Poignet JL, Geddes C, et al. The changing epidemiology of hepatitisCvirus (HCV) infection in haemodialysis: European Multicentre Study
Ayman Geddawy, Yasmine F. Ibrahim, Nabil M. Elbahie and Mohammad A. Ibrahim
Globally, the chronic hepatitisCvirus (HCV) is a leading cause of liver diseases such as liver cirrhosis and hepatocellular carcinoma. It affects approximately 180 million people worldwide; about 3% of the world population.  Three to four million persons are newly infected each year, with the predominant prevalence being infection with genotype 1, followed by genotypes 2 and 3. The other genotypes, 4, 5, and 6, have specific geographical distribution. The infection with HCV occurs as the result of percutaneous transmission via infectious
Akanksha Singh, Dhananjay Singh Mankotia and Mohammad Irshad
HepatitisCvirus (HCV) infection is a serious global health problem infecting 3-4 million people each year.[ 1 ] HCV infection presents both as asymptomatic as well as symptomatic infection. A high proportion of patients infected with HCV develop chronic liver diseases that result in cirrhosis of liver and hepatocellular carcinoma (HCC) in later stage. HCV infection is an indication for liver transplant all over the world.[ 2 ] Patients with HCV usually show a poor response to antiviral therapy with a high relapse rate of HCV infection after
Tünde Tőrők-Vistai, Manuela Sfichi, Anca Bojan and Cristina Pojoga
1. Turner NC, Dusheiko G and Jones A. Hepatitis C and B-cell lymphoma. Ann Oncol 2003;14:1341-1345
2. Zignego AL, Gianinni C, Ferri C. HepatitisCvirus-related lymphoproliferative disorders: an overview. World J Gastroenterol 2007;13(17):2467-2475.
3. Vlădăreanu A-M. Limfoamele în corelaţie cu virusurile limfotrope. Editura Amaltea 2007.Cap. Limfoamele maligne şi virusurile hepatitice. Pag. 63-93
4. Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longombardo G et al
Osman Ezat, Esmat Gamal, Adela Gad, Eissa Soliman, El Abgeegy Mohammad and Atteyate Hatia
Frank C, Mohamed M, Strickland T, Lavanchy D, Arthur RR, Magder LS, El Khoby T, Abdel-Wahab Y, Aly Ohn ES, Anwar W and Sallam I. The role of parental antischistosomal therapy in the spread of HCV in Egypt. Lancet. 2000;355(9207):887-9 1.
Kamal SM. Improving outcomes in patients with hepatitisCvirus genotype 4. Am J Gastroenterol. 2007;102(11):2582-8.
Schmeding M, Neumann UP, Puhl G, Bahra M, Neuhaus R, Neuhaus P. Hepatitis C Recurrence and Fibrosis Progression Are Not
Jun Cheng, Min Li, Ping Gao, Jin-ling Dong and Qi Wang
1. Chang ML, Yeh HC, Tsou YK, Wang CJ, Cheng HY, Sung CM, et al. HCV core-induced nonobese hepatic steatosis is associated with hypoadiponectinemia and is ameliorated by adiponectin administration. Obesity (Silver Spring) 2012; doi: 10.1038/ oby.2012.45.
2. Sato S, Fukasawa M, Yamakawa Y, Natsume T, Suzuki T, Shoji I, et al. Proteomic profiling of lipid droplet proteins in hepatoma cell lines expressing hepatitisCvirus core protein. J Biochem 2006;139:921-930.
3. Congiu M, Ryan MC, Desmond PV. No